pLPhygCAS9 Citations (2)

Originally described in: CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
Zhang WW, Matlashewski G MBio. 2015 Jul 21;6(4). pii: e00861-15. doi: 10.1128/mBio.00861-15. PubMed Journal

---

Articles Citing pLPhygCAS9

Articles
Thiophene derivatives activity against the protozoan parasite Leishmania infantum. Bigot S, Leprohon P, Vasquez A, Bhadoria R, Skouta R, Ouellette M. Int J Parasitol Drugs Drug Resist. 2023 Apr;21:13-20. doi: 10.1016/j.ijpddr.2022.11.004. Epub 2022 Nov 25. PubMed
CRISPR-Cas9 high-throughput screening to study drug resistance in Leishmania infantum. Queffeulou M, Leprohon P, Fernandez-Prada C, Ouellette M, Mejia-Jaramillo AM. mBio. 2024 Jul 17;15(7):e0047724. doi: 10.1128/mbio.00477-24. Epub 2024 Jun 12. PubMed

If you have published an article using this material, please email us at to have your article added to this page.